ArticleCancer immunology, immunotherapy : CII2026

Hematological toxicities and thrombosis risk associated with immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2024.

Jingyi Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.